Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids.
-
Authors
-
-
Hernandez, Daniela1
-
Palau, Laura1
-
Norsworthy, Kelly1
-
Anders, Nicole M1
-
Alonso, Salvador1
-
Su, Meng1
-
Petkovich, Martin2
-
Chandraratna, Rosh3
-
Rudek, Michelle A1
-
Smith, B Douglas1
-
Jones, Richard J1
-
Ghiaur, Gabriel4
-
1
Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University, 1650 Orleans St. Room 243, Baltimore, MD, 21231, USA.
-
2
Cancer Research Institute, Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
,
(Canada)
-
3
IO Therapeutics, Santa Ana, CA, USA.
-
4
Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University, 1650 Orleans St. Room 243, Baltimore, MD, 21231, USA. [email protected]
- Type
- Published Article
- Journal
-
Leukemia
- Publisher
-
Springer Nature
- Publication Date
-
Nov 01, 2020
- Volume
-
34
- Issue
-
11
- Pages
-
3077–3081
- Identifiers
-
DOI: 10.1038/s41375-020-0790-4
-
PMID: 32152463
- Source
-
Medline
- Language
-
English
- License
-
Unknown
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 11/12/2020 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/32152463
